Monitor subsequent filings for updates on the investigation's findings, any regulatory inquiries (HIPAA, FTC), and potential remediation costs or legal liabilities if patient data was compromised.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 5 $6.29entry
- T+1 · 11d ago −5.88%α −6.19% · $5.92
- T+5 · 5d ago −9.70%α −12.99% · $5.68
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Myriad Genetics disclosed a cybersecurity incident on November 2, 2026, involving unauthorized access to its IT network. The company temporarily suspended testing operations and order management systems, and most systems have since returned to normal. Management does not believe the incident will have a material adverse effect on its business, but the investigation into the scope, including potential patient record access, is ongoing.
Key Facts
- Unauthorized access detected on November 2, 2026
- Testing operations and order management systems temporarily suspended
- Most systems have returned to normal operations
- External experts engaged to assist investigation
- Full scope of unauthorized access remains under investigation, including potential patient record access
- Company does not believe the incident will have a material adverse effect on its business
Financial Impact
No financial impact quantified in the filing; company states belief that incident will not have a material adverse effect
Risk Factors
- Potential regulatory penalties or litigation if patient records were accessed
- Reputational damage and loss of customer trust
- Possible future costs for remediation, credit monitoring, or legal defense
- Investigation is ongoing and scope of impact is not yet fully known
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-070659 |
| Document: 0001628280-26-070659-index-headers.html | 0001628280-26-070659 |
| Document: 0001628280-26-070659-index.html | 0001628280-26-070659 |
| Document: 0001628280-26-070659.txt | 0001628280-26-070659 |
Track record
16 reports on MYGN
3 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +13.54% at T+5 after the Oct 20, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $5.57 Now $5.57 −0.00% settles Nov 18
- Nov 9, 20267d ago 8-K Neutral 2/10 Entry $5.67 to $5.72 Now $5.57 −1.76% ▲ +0.88% −0.44% vs SPY
- Nov 5, 202611d ago 8-K Neutral 4/10 Viewing Entry $6.29 to $5.92 Now $5.57 −11.45% ▼ −5.88% −6.19% vs SPY
- Nov 4, 202612d ago 8-K Mixed 6/10 Entry $6.29 to $5.92 Now $5.57 −11.45% ▼ −5.88% −6.19% vs SPY
- Nov 4, 202612d ago Institutional Cluster Neutral 2/10 Entry $6.02 to $6.29 Now $5.57 −7.48% ▲ +4.49% +8.89% vs SPY
- Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $6.63 to $6.67 Now $5.57 −15.99% ▲ +0.60% +0.99% vs SPY
- Oct 20, 202627d ago 8-K Bullish 7/10 Entry $5.54 to $5.57 Now $5.57 +0.54% ▲ +0.54% +0.02% vs SPY
- Oct 15, 20264w ago Press Release Neutral 1/10 Entry $3.98 Now $5.57 +39.95% No price data
- Oct 9, 20265w ago 8-K Neutral 3/10 Entry $4.20 to $4.08 Now $5.57 +32.62% ▼ −2.86% −2.85% vs SPY
- Sep 16, 20268w ago 8-K Neutral 3/10 Entry $3.86 to $4.14 Now $5.57 +44.30% ▲ +7.25% +6.12% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers